AKT1 and nasopharyngeal carcinoma: To examine the effects of the GSK690693 AKT inhibitor on NPC cells during radiotherapy in vivo, clone formation was compared in the untreated, GSK69069- or IR-treated and IR and GSK690693-cotreated NPC cell groups (Fig. 4A and B).